| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO
1 company
Bashan Dror is a President And CEO at Protalix BioTherapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $407K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | PLX Protalix Biotherapeutics, Inc. | President And CEO | Buy | 56,000 | $1.81 | $101,360.00 | +42.3% | +28.9% | - | |
| Oct 19, 2023 | PLX Protalix Biotherapeutics, Inc. | President And CEO | Buy | 64,516 | $1.40 | $90,483.69 | +35.0% | +5.5% | -25.3% | |
| Apr 11, 2022 | PLX Protalix Biotherapeutics, Inc. | President And CEO | Buy | 68,000 | $1.50 | $102,000.00 | New | -21.6% | +66.7% |